Fangsheng Pharmaceutical: Net profit in the first half of 2025 increased by 23.67% year-on-year.

Fangsheng Pharmaceutical announced that the operating income in the first half of 2025 was 834 million yuan, a year-on-year decrease of 8.35%. The net profit was 169 million yuan, a year-on-year growth of 23.67%. The company plans to distribute a cash dividend of 1.5 yuan per 10 shares to all shareholders.